Find helpful information and videos and support for Tyvaso, a prescription medicine approved for adults with pulmonary arterial hypertension (PAH) (WHO Group 1).
logo

Terms of use

Terms of use agreement

This website may contain information about United Therapeutics Corporation, its subsidiaries and affiliates (collectively, "Company"), and/or one or more product marketed by Company. Access to and use of this website is subject to the following terms and conditions and all applicable laws. By accessing and using the website, you agree to be bound by and to comply with this Terms of Use Agreement without limitation or qualification and you acknowledge that it supersedes any other agreement between you and Company regarding this subject matter. If you do not agree with these Terms of Use, please exit and do not use the website. These terms of use may be revised by Company from time to time and you should therefore review them on your next visit to the website. Your continued use of the website following any such posting will be deemed as consent to the new notice, term or condition.

  • a)

    You may browse this website. You may download and print material from this website, provided that you retain all copyright and trademark notices contained in such materials. You may use such downloaded and printed materials for your own personal, non-commercial use. You may not use in any manner such materials for public or commercial purposes without Company’s express written consent.

  • b)

    All product names, logos and service marks displayed on this website that are identified by “™” or “®” or that appear in type form different from that of the surrounding text are trademarks owned by or licensed to Company or our affiliates (collectively, “Trademarks”), unless otherwise identified as being owned by another entity. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right, either express or implied, under any patent or Trademark of Company or any third party. No use of any Trademark may be made without the prior written authorization of Company, except to identify the product or services of the company.

  • c)

    Company’s products are available only by prescription from licensed health care professionals. Company does not provide medical advice or services.

  • d)

    You should assume that all content of the website is protected by copyright law unless otherwise noted and may not be used except as provided herein, or with the express written permission of Company. Except as expressly provided above, nothing contained herein shall be construed as conferring any license or right under any Company copyright.

  • e)

    You are prohibited from posting or transmitting to the website any unlawful, threatening, libelous, defamatory, obscene, inflammatory, pornographic or profane material or any material that could constitute or encourage conduct that would be considered a criminal offense, give rise to civil liability or would otherwise violate the law. Company will fully cooperate with any law enforcement authorities or court order requesting or directing Company to disclose the identity of anyone posting any such information or materials.

Disclaimer

COMPANY MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND OR NATURE WITH RESPECT TO ANY OF THE INFORMATION CONTAINED ON THIS WEBSITE. COMPANY DISCLAIMS ALL REPRESENTATIONS AND/OR WARRANTIES, EXPRESS OR IMPLIED, CREATED BY LAW, CONTRACT OR OTHERWISE, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE OR NONINFRINGEMENT.

In no event shall Company be liable for any damages of any kind or nature, including without limitation, direct, indirect, special, consequential or incidental damages arising from or in connection with the existence or use of the website and/or the information.

Important Safety Information for Tyvaso

Before you take Tyvaso, tell your healthcare provider about all of your medical conditions, including if you:

  • Have lung disease, such as asthma or chronic obstructive pulmonary disease (COPD)
  • Have a lung infection
  • Have liver or kidney problems
  • Have low blood pressure
  • Have bleeding problems
  • Are pregnant or plan to become pregnant. It is not known if Tyvaso will harm your unborn baby.
  • Are breast-feeding or plan to breast-feed. It is not known if Tyvaso passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with Tyvaso.

Tell your healthcare provider about all the medicines you take , including prescription and over-the-counter medicines, vitamins, and herbal supplements. Tyvaso and other medicines may affect each other.

Especially tell your healthcare provider if you take:

  • Medicines used to treat high blood pressure or heart disease
  • Medicines that decrease blood clotting (anticoagulants)
  • Water pills (diuretics)
  • Gemfibrozil (Lopid) or rifampin (Rimactane, Rifadin, Rifamate, Rifater)

What are the possible side effects of Tyvaso?

Tyvaso can cause serious side effects, including:

  • Low blood pressure (symptomatic hypotension). If you have low blood pressure, Tyvaso may lower your blood pressure more
  • Bleeding problems. Tyvaso may increase the risk of bleeding in people who take blood thinners (anticoagulants)

The most common side effects of Tyvaso are cough, headache, throat irritation and pain, nausea, reddening of the face and neck (flushing), fainting or loss of consciousness, dizziness, and diarrhea. These are not all the possible side effects of Tyvaso. Call your doctor for medical advice about side effects.

You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.

What is Tyvaso?

Tyvaso (treprostinil) is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH; WHO Group I), which is high blood pressure in the arteries of your lungs. Tyvaso can improve the ability to exercise. Your ability to exercise decreases 4 hours after taking Tyvaso. It is not known if Tyvaso is safe and effective in children under 18 years of age.

TYVISIdtcOCT17

Please see the Full Prescribing Information, Patient Product Information, and the Tyvaso Inhalation System Instructions for Use manual.

For additional information about Tyvaso, visit www.tyvaso.com or call 1-877-UNITHER (1-877-864-8437).

This information is provided for an informational purpose and is not intended as treatment advice. Patients should consult a healthcare professional for treatment advice.

The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE to return to the consumer section of the site.
Close
Yes, I am a US healthcare professional and would like to continue
Continue